Latest Updates
-
Rich Mughlai Special Chicken Korma Recipe -
A Hidden Foodborne Infection: What You Should Know About Cyclospora -
Melt-in-Mouth Sweet Mysore Pak Recipe: A Classic Indian Delight -
Between Meetings and Meals: Why American Pecans Are the Ideal Midday Snack -
Skincare Hacks 101: 7 Summer Hacks That Actually Work in 40°C Heat -
8 Workouts That Should Be a Part of Everyone’s Lifestyle for Longevity -
Simple Everyday Dal Recipe: Your Go-To Chana Dal -
Italian PM Giorgia Meloni’s ‘Desi’ Look Wins Internet with Jhumkas -
May 2026 Bank Holidays in India: Check Complete State-Wise List -
What To Watch This Week (April 20–26): New OTT Releases Across Netflix, JioHotstar, Prime Video, ZEE5 And More
Deep Brain Stimulation

Patients with treatment-resistant depression showed significant improvements in their condition after undergoing deep brain stimulation (DBS), nearly a month after the treatment.
DBS uses high-frequency electrical stimulation targeted to the specific areas of the brain involved in neuropsychiatric disease.
During the study, twenty patients were treated with DBS for 12 months. The team found that twelve of 20 patients experienced a significant decrease in depressive symptoms by six months with seven patients essentially well with few remaining symptoms
Benefits were largely maintained at 12 months with continued stimulation. No long-term side effects were reported.
Each patient was implanted with two thin wire electrodes (one on each side of the brain) in the white matter adjacent to subcallosal cingulate region or SCG.
The other end of each wire was connected under the skin of the neck to a pulse generator implanted in the chest - similar to a pacemaker - that directs the electrical current.
The researchers regulated the intensity of the current according to the response of the patient.
"In previous studies using brain imaging, we found the subcallosal cingulate region was a key region in an emerging emotion regulation circuit implicated in major depression," said Helen S. Mayberg, MD, lead researcher from University of Toronto.
"We postulated that if stimulation worked for the treatment of other neurological disorders where abnormal function of specific circuits was well established, such as Parkinson's disease, then stimulation of the Cg25 region within this apparent depression circuit might provide significant benefit for patients with treatment-resistant depression," she added.
The team included researchers from University of Toronto and Emory University School of Medicine.
The study is reported in the online issue of Biological Psychiatry.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications